Validation and Adaptation of the Modified Transplant Symptom Occurrence and Symptom Distress Scale-59 Items Revised into Turkish

2013 ◽  
Vol 23 (4) ◽  
pp. 392-400 ◽  
Author(s):  
Yaprak S. Ordin ◽  
Özgül Karayurt ◽  
Özgül Vupa Çilengiroğlu
2001 ◽  
Vol 9 (2) ◽  
pp. 115-134 ◽  
Author(s):  
Philip Moons ◽  
Sabina De Geest ◽  
Kristel Versteven ◽  
Ivo Abraham ◽  
Hans Vlaminck ◽  
...  

The aim of this study was to assess key aspects of the reliability and validity of the “Modified Transplant Symptom Occurrence and Distress Scale,” an instrument measuring symptom experience associated with side effects of triple drug therapy in transplant patients. This cross-sectional, comparative study included 108 renal transplant recipients (61% men; 39% women) with a median age of 47 years and a median posttransplant status of 5.5 years. Renal transplant patients were matched by age and gender with 108 healthy control persons not taking immunosuppressive drugs. Content validity, construct validity and discriminant validity of the instrument were substantiated. Internal consistency reliability was not useful to assess in this instrument, as the conditions for calculating Cronbach’s alpha were not satisfied. These findings document the validity of the “Modified Transplant Symptom Occurrence and Symptom Distress Scale” as an instrument to measure symptom experience with immunosuppressive drugs.


2010 ◽  
Author(s):  
Xue-Ling Yang ◽  
Huan-Huan Li ◽  
Ming-Huang Hong ◽  
Henry S. R. Kao

Author(s):  
Ruth McCorkle ◽  
Katherine Young

1978 ◽  
Vol 1 (5) ◽  
pp. 373???378 ◽  
Author(s):  
RUTH MCCORKLE ◽  
KATHERINE YOUNG

2016 ◽  
Vol 39 (4) ◽  
pp. E9-E23 ◽  
Author(s):  
Stephen J. Stapleton ◽  
Janean Holden ◽  
Joel Epstein ◽  
Diana J. Wilkie

2006 ◽  
Vol 24 (18_suppl) ◽  
pp. 8579-8579
Author(s):  
S. A. Bernard ◽  
C. B. Lee ◽  
B. Usher ◽  
B. Qaqish ◽  
R. Schwartz ◽  
...  

8579 Background: Level of consciousness (LOC) often varies in the palliative care patient population. Tools are needed to reliably rate symptoms. The purpose of our analysis was to describe the patient demographics and rating distributions elicited by two distinct measurement tools, one for those able to self-rate (SR) and one for proxy-rated (PR) patients. Methods: Data obtained prospectively over the time period 1/2002–12/2004 was reviewed. A symptom distress scale using 11 items on a 5 point Likert-type scale (5=most severe) was adapted from the revised McCorkle symptom distress scale and used for alert and oriented patients. Symptoms evaluated included nausea, mood, appetite, shortness of breath (SOB), insomnia, pain, mobility, fatigue, constipation, decreased LOC, and delirium. For patients unable to SR, an advanced practice nurse rated symptoms using the Detroit Medical Center non-verbal pain scale and proxy symptom distress measures adapted from the Common Toxicity Criteria Manual, version 2. Rated symptoms included pain, vomiting, constipation, tachypnea, depressed LOC, and agitated delirium. Results: A total of 259 patients with data from visits 1 and 2 were included in the analysis. On visit 1, 46% (61/133) of PR patients were male, 70% (94/134) were ≥60yrs and 73% (98/134) were Caucasian. Symptom distress scores varied by rater and visit (Table). Conclusions: There is a need for proxy symptom distress measurement in the palliative care patient population as LOC fluctuates. Variability in symptom distress ratings between the SR and PR groups, with a trend toward lower scores in PR patients, is in accordance with the current literature. Of note, there was a consistent improvement in scores, regardless of rater, when visit 2 was compared to visit 1. We plan a prospective study of inter-rater reliability and validity of this novel symptom scoring system. [Table: see text] No significant financial relationships to disclose.


Sign in / Sign up

Export Citation Format

Share Document